Table 2.

Best tumor response evaluated by mRECIST

mRECIST	Total enrolled Patients (n = 114)	SBRT + LEN group (n = 37)	LEN group (n = 77)	Pa value
Complete response, n (%)	4 (3.5%)	3 (8.1%)	1 (1.3%)	0.100
Partial response, n (%)	32 (28.1%)	18 (46.8%)	15 (19.5%)	0.001
Stable disease, n (%)	48 (42.1%)	13 (35.1%)	34 (44.2%)	0.360
Progressive disease, n (%)	30 (26.3%)	3 (8.1%)	27 (35.1%)	0.005
ORR, n (%)	36 (31.6%)	21 (56.8%)	16 (20.8%)	0.000
DCR, n (%)	84 (73.7%)	34 (91.9%)	50 (64.9%)	0.005

mRECIST modified Response Evaluation Criteria in Solid Tumors, ORR objective response rate = complete response rate + partial response rate

^aBold values indicate statistical significance